Johnson & Johnson (USD)
JNJ
Overview
Key Information
Legal Documents
Financials
Overview
| Sector | Healthcare |
| Industry | - |
| Day Range | 159.11 | 161.41 |
| 52-Wk Range | - | - |
| Last Close | 160.30 |
| Mkt Cap (m) | 421,996.59 |
| Dividend yield | 2.48 |
| ISIN | US4781601046 |
| Volume | 7,630,813.00 |
| Exchange Venue | NYS |
Company Profile
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.
Key Information
| Price/Earning | 25.20 |
| Price/Book | 6.54 |
| Price/Sales | 5.30 |
| P/CF | 19.83 |
| Rev Growth (3 year avg) | - |
| EPS Growth (3 year avg) | - |
| Operating Margin % | - |
| Net Margin % | - |
| Return on Equity | - |
| Debt/Equity | - |
Documents
Prospectus
| en 24/08/2020 |
Annual Report
| en 29/12/2019 |
Please refer to the below issuer website for further documents.
Financials
Income Statement
| USD | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
| Revenue (m) | 70,074.00 | 71,890.00 | 76,450.00 | 81,581.00 | 82,059.00 | - |
| Operating Income (m) | 18,065.00 | 21,136.00 | 18,714.00 | 20,049.00 | 20,080.00 | - |
| Net Income (m) | 15,409.00 | 16,540.00 | 1,300.00 | 15,297.00 | 15,119.00 | - |
| Basic EPS | 5.56 | 6.04 | 0.48 | 5.70 | 5.72 | - |
| Avg. Diluted Shares Outstanding (m) | 2,812.90 | 2,788.90 | 2,745.30 | 2,728.70 | 2,684.30 | - |
Balance Sheet
| USD | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
| Current Assets (m) | 60,210.00 | 65,032.00 | 43,088.00 | 46,033.00 | 45,274.00 | - |
| Non Current Assets (m) | 73,201.00 | 76,176.00 | 114,215.00 | 106,921.00 | 112,454.00 | - |
| Total Assets (m) | 133,411.00 | 141,208.00 | 157,303.00 | 152,954.00 | 157,728.00 | - |
| Current Liabilities (m) | 27,747.00 | 26,287.00 | 30,537.00 | 31,230.00 | 35,964.00 | - |
| Total Liabilities (m) | - | - | - | - | - | - |
| Total Equity (m) | 71,150.00 | 70,418.00 | 60,160.00 | 59,752.00 | 59,471.00 | - |
Cash Flows
| USD | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
| Operating Cash Flows (m) | 19,279.00 | 18,767.00 | 21,056.00 | 22,201.00 | 23,416.00 | - |
| Capital Expenditure (m) | -3,463.00 | -3,226.00 | -3,279.00 | -3,670.00 | -3,498.00 | - |
Figures are quoted in USD unless stated otherwise
-
No change
$
160.30
Last Price
© 2019 MeDirect Bank (Malta) plc. All rights reserved.